Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2351297 | 0.98 | TSHR (0.46) | TSHRPPARD | |
| SCHEMBL40352 | 0.94 | TSHR (0.50) | TSHRPPARDTP53TDP1 | |
| SCHEMBL5201343 | 0.85 | TSHR (0.54) | TSHRPPARDTP53TDP1 | |
| SCHEMBL7268189 | 0.82 | PPARD (0.64) | TSHRPPARDTP53TDP1 | |
| SCHEMBL11514496 | 0.80 | PPARD (0.61) | TSHRPPARDTP53TDP1 | |
| SCHEMBL7268183 | 0.80 | PPARD (0.61) | TSHRPPARDTP53TDP1 | |
| SCHEMBL11323349 | 0.80 | PPARD (0.61) | TSHRPPARDTP53TDP1 | |
| SCHEMBL7716774 | 0.80 | TSHR (0.48) | TSHRPPARD | |
| SCHEMBL11524014 | 0.78 | TSHR (0.46) | TSHRPPARD | |
| SCHEMBL5017294 | 0.78 | PPARD (0.64) | TSHRPPARDTP53TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8629266-B2 | Dendritic starch-based dextrin adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-14 | — | — | US | disclosed |
| US-8629266-B2 | Dendritic starch-based dextrin adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2014-01-14 | — | — | US | disclosed |
| WO-2013070204-A1 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| US-20130116422-A1 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-20130116422-A1 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-05-09 | — | — | US | disclosed |
| US-8382889-B1 | Dendritic starch-based dextrin adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-02-26 | — | — | US | disclosed |
| US-8382889-B1 | Dendritic starch-based dextrin adhesives | EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) | 2013-02-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130116422-A1 | DENDRITIC STARCH-BASED DEXTRIN ADHESIVES | CD14, STT3B, STT3A | TSHR 4874/4885PPARD 1790/4885TP53 2512/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.